Biosimilars in the Era of Artificial Intelligence-International Regulations and the Use in Oncological Treatments

• Egile Nagusiak: Tomas Gabriel Bas (Egilea), Vannessa Duarte (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

This research is based on three fundamental aspects of successful biosimilar development in the challenging biopharmaceutical market. First, biosimilar regulations in eight selected countries: Japan, South Korea, the United States, Canada, Brazil, Argentina, Australia, and South Africa, represent th...